Asian Journal of Case Reports in Medicine and Health

Unilateral Normotensive Angle Closure as a Presenting Feature of Vogt-Koyanagi-Harada Disease

Saadiya Hawa *

Stanford University, CA, USA.

*Author to whom correspondence should be addressed.

---

Abstract

We describe an atypical presentation of probable Vogt-Koyanagi-Harada Disease with unilateral angle closure and normal intraocular pressure in a young male. On Ultrasonographic Biomicroscopy, there was anterior rotation of ciliary processes with supraciliary effusion. Fundus Fluorescein Angiography showed early phase hyperfluorescent spots followed by leakage and pooling, typical of VKHD. The angle closure responded to intravenous methyl prednisolone followed by tapered oral steroids. It is necessary for the ophthalmologist to be aware of this presentation so that there is no delay in initiating the required therapy and the patient does not have to undergo various unnecessary procedures like laser iridotomies.

Keywords: Angle closure glaucoma, ophthalmology, uveitis, Vogt-Koyanagi-Harada disease

---

---

---

References

Takemoto D, Ijiri S, Shimizu M, Higashide T, Sugiyama K. Two cases of vogt-koyanagi-harada disease presenting shallow anterior chamber. Nippon Ganka Gakkai Zasshi. 2015;119(5):354-362.

Rathinam SR, Namperumalsamy P, Nozik RA, Cunningham ET. Angle closure glaucoma as a presenting sign of vogt–koyanagi–harada syndrome. British Journal of Ophthalmology. 1997;81(7): 608-608.

DOI: 10.1136/bjo.81.7.608a

O’Keefe GAD, Rao NA. Vogt-koyanagi-harada disease. Survey of Ophthalmology. 2017;62(1):1-25.

DOI: 10.1016/j.survophthal.2016.05.002

Shindo Y, Ohno S, Nakamura S, Onoé K, Inoko H. A significant association of HLA-DPB1*0501 with vogt-koyanagi-harada’s disease results from a linkage disequilibrium with the primarily associated allele, DRB1*0405. Tissue Antigens. 1996; 47(4):344-345.

DOI: 10.1111/j.1399-0039.1996.tb02565. x

Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, Sakuragi S. Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in lewis rats. Experimental Eye Research. 2000;71(4):361–369.

DOI: 10.1006/exer.2000.0893

Yang P, Liu X, Zhou H, Guo W, Zhou C, Kijlstra A. Vogt-koyanagi-harada disease presenting as acute angle closure glaucoma at onset. Clinical & Experimental Ophthalmology. 2011;39(7):639-647.

DOI: 10.1111/j.1442-9071.2011.02523.x

Read RW, et al. Revised diagnostic criteria for vogt-koyanagi-harada disease: Report of an international committee on nomenclature11 the authors constitute the international committee on vogt-koyanagi-harada disease nomenclature, representing the participants of the first international workshop on vogt-koyanagi-harada disease. A full list of participants appears at the end of the article. American Journal of Ophthalmology. 2001;131(5): 647-652.

DOI: 10.1016/S0002-9394(01)00925-4

Yang P, et al. Development and evaluation of diagnostic criteria for vogt-koyanagi-harada disease. JAMA Ophthalmology. 2018;136(9):1025-1031.

DOI:10.1001/jamaophthalmol.2018.2664

Herbort CP, et al. Precise, simplified diagnostic criteria and optimised management of initial-onset vogt-koyanagi-harada disease: An updated review. Eye. 2022;36(1):1.

DOI: 10.1038/s41433-021-01573-3

Lodhi SA, Reddy JL, Peram V. Clinical spectrum and management options in vogt-koyanagi-harada disease. Clin Ophthalmol. 2017;11:1399–1406.

DOI: 10.2147/OPTH.S134977

Hiyama T, Harada Y, Kiuchi Y. Clinical characteristics and efficacy of adalimumab and low-dose methotrexate combination therapy in patients with vogt-koyanagi- harada disease. Frontiers in Medicine. 2022;8.

Available:https://www.frontiersin.org/articles/10.3389/fmed.2021.730215